From the category archives:

Pharmacy news

What You Should Know about the Acetaminophen Recall

by pharmacy on November 25, 2015

acetaminophen recallMedline Industries, a Massachusetts-based medical and pharmaceutical device supplier, is voluntarily recalling a single lot of acetaminophen tablets. This recall applies to lot number 45810, which contains 500 mg acetaminophen tablets, but they may have been labeled to indicate 325 mg. [click to continue…]


over the counter cough medicines for minorsNew Jersey Governor Chris Christie has enacted a law to ban the sale of over-the-counter cough medicine products that contain dextromethorphan (DXM) to patients under the age of 18 without a prescription. The law comes as a result of an alarming number of youth abusing the cough suppressant, which can be found in more than 120 over the counter cough and cold medications, including TheraFlu, Robitussin, and NyQuil. [click to continue…]


No Syringe Approved for Standalone Storage

by pharmacy on November 4, 2015

syringe standalone storageAccording to the FDA, pharmacies and other facilities are no longer allowed to store sterile compounding preparations or repackaging sterile form of pseudocode in any syringes for drug administration. The practice, though common, has never been cleared or approved by the FDA. [click to continue…]


FDA Approves Antihemophilic Factor Preparation

by pharmacy on October 21, 2015

Nuwiq_Recombinant_AntihemophilicA recombinant antihemophilic factor preparation produced by human cells has been approved by the FDA for use in patients who have hemophilia A.

According to the product labeling, it is intended to provide “on-demand” treatment and control of bleeding episodes. It is also intended to help with routine bleeding prophylaxis and the management of bleeding prior to an operation.

The new medication, known as Nuwiq, is manufactured by Swedish company, Octapharma AB. It will be distributed by Octapharma USA, Inc. here in the United States. The company aims to have the product available in the United States in early 2016.

The product will be available in single-use vials, containing 250, 500, 1000, or 2000 IU of the freeze-dried factor. Each vial is to be packaged with a syringe filled with 2.5 mL of water for injection, with a vial adapter, a butterfly needle, and a couple of alcohol swabs.

The vials are intended to be stored at 35.6 to 46.4 degrees. They can be stored at room temperature, up to 77 degrees, for up to three months.

After the vial is reconstituted, the solution must be kept at room temperature, and has to be used within three hours.

Adolescents aged 12 to 17 and adults should be given 30 to 40 IU/kg of body weight every other day for routine prophylaxis. Children aged two to 11 should be given 30 to 50 IU/kg of body weight every other day, or three times a week.

The frequency and duration of therapy will depend on the severity of the FVIII deficiency, the location and extent of blending, and the clinical condition of the patient.

In pediatric use for children aged two to five, higher doses and more frequent dosing is suggested for prophylactic treatment. There is a lower recovery, shorter half life, and faster clearance in children aged two to 11, so this should be considered.

Minor bleeding episodes can be treated with 20 to 40 IU/dL every 12 to 24 hours for at least a day or until the bleeding episode stops. Moderate to major bleeding episodes should be treated with 30 to 60 IU/dL every 12 to 24 hours for at least three to four days, or until the bleeding stops. For life-threatening episodes, 50 to 100 IU/dL should be administered every eight to 24 hours until the bleeding risk is resolved.

Clinical trials showed the following frequently reported side effects: headache, injection site pain and inflammation, vertigo, dry mouth, paresthesia, back pain, and the formation of non neutralizing antibodies to factor VIII, though they don’t present any inhibitory activity.


Medical Home Onsite Pharmacist Program Successful

by pharmacy on October 14, 2015

onsite_pharmacist_programFewer than 12 months after an old insurance company decided to start funding pharmacists in six patient-centered medical homes, Blue Cross and Blue Shield of Rhode Island has decided that the program is successful and is planning to expand it. [click to continue…]


Safety Culture Includes “Good Catches”

by pharmacy on October 7, 2015

pill safety pharmacist hospitalHospitals working to recognize interceptions of medication errors or other safety related issues before they make it to the patient show that doing the right thing can be personally rewarding while supporting the hospital’s effort to continuously improve patient care. [click to continue…]


Page 1 of 4412345...Last »
© RPh on the Go, All Rights Reserved.